+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID05283356

Comparing Ticagrelor and Aspirin as Single Antiplatelet Treatments After Transcatheter Aortic Valve Implantation for Severe Aortic Valve Stenosis

Led by Fundacin Biomedica Galicia Sur · Updated on 2026-07-28

1206

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the best medication to use after transcatheter aortic valve implantation TAVI to prevent valve blood clots and reduce complications like stroke without causing too much bleeding. This trial compares two single antiplatelet therapies, Aspirin and Ticagrelor, to find the most suitable option, especially for patients who have other chronic conditions like coronary artery disease, diabetes, or peripheral vascular disease. These conditions raise the risk of complications after TAVI, making this research important for improving patient care. Participants will receive either Aspirin 100 mg once daily or Ticagrelor 60 mg twice daily after their TAVI procedure. The study randomly assigns patients to one of these two treatments to evaluate and compare their safety and effectiveness. Both treatments aim to reduce the chance of blood clots and thromboembolic events, and the study follows patients for at least 12 months to assess outcomes including valve thrombosis, major bleeding, and other patient-related health events. During the study, participants will be regularly monitored through clinical visits to assess safety and treatment effects. Researchers will measure the occurrence of major adverse cardiac and cerebrovascular events NACE at 12 months as the primary outcome. Secondary assessments include checking for subclinical valve thrombosis at 3 and 12 months, major bleeding events, and composite patient outcomes. Participants must attend follow-up visits to track progress and ensure safety throughout the study period, which may last up to several years.

CONDITIONS

Brief Title

Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation

Research Team

V

Victor A Jiménez Díaz, MD, MPH

P

Pablo Juan-Salvadores, Pharma, MPH, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here